Skip to content

LanzaTech Global, Inc. LNZA Joint development agreements — Total revenues

Other product segments

CarbonSmart product
$4.05M-3.7%
Revenue from grant contributions included in Engineering and other services above
$2.88M+5,127%
Contract research
$989K-28.1%
Licensing
$595K-43.4%

Similar metrics at other companies

BioCryst Pharmaceuticals logo
BCRXCollaborative and other revenues — Total revenues
$2M+14.3%
Arcus Biosciences logo
RCUSOther collaboration — Total revenues
$5M-37.5%
Viridian Therapeutics, Inc. logo
VRDNCollaboration — Total revenues
$135K+35.0%
Arcus Biosciences logo
RCUSLicense and development services — Total revenues
$12M-40.0%
Quanterix Corporation logo
QTRXCollaboration and license revenue — Total revenues
$560K-27.4%
Aquestive Therapeutics, Inc. logo
AQSTCo-development and research fees — Revenue
$258K-38.3%

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-77.6%
Enterprise value$72.09M-77.0%
P/S1.3×-7.1×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%
Debt / equity0.3×
Current ratio-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s joint development agreements — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LanzaTech Global, Inc.'s joint development agreements — total revenues?
LanzaTech Global, Inc. (LNZA) reported joint development agreements — total revenues of $0 in Q1 2026.
How has LanzaTech Global, Inc.'s joint development agreements — total revenues changed year-over-year?
LanzaTech Global, Inc.'s joint development agreements — total revenues decreased by 100.0% year-over-year, from $1.05M to $0.
What is the long-term trend for LanzaTech Global, Inc.'s joint development agreements — total revenues?
Over 3 years (2022 to 2025), LanzaTech Global, Inc.'s joint development agreements — total revenues has grown at a -26.2% compound annual growth rate (CAGR), from $6.02M to $2.43M.
What does joint development agreements — total revenues mean?
This metric represents the total revenue recognized from collaborative research and development partnerships aimed at commercializing carbon-refining technologies. It captures the financial value generated through shared innovation projects where the company partners with third parties to develop sustainable chemical building blocks. Tracking this revenue stream provides insight into the company's ability to monetize its proprietary technology pipeline through strategic industry alliances.